Review finds preliminary reproductive signals, but no demonstrated infertility

Synthetic cannabinoid exposure and the male reproductive system: A review of disruptive mechanisms in preclinical models.

Reproductive toxicology (Elmsford, N.Y.) • • Review • Highly Relevant
🤖

AI Summary

This narrative review asks whether exposure to synthetic cannabinoids (SCBs) affects the male reproductive system. It synthesizes compound-specific preclinical studies, mainly in rodents, alongside available human evidence, and qualitatively appraises study quality and how closely exposure models reflect real-world use. The review found preliminary, varying signals involving sperm measures, testosterone, testicular tissue, and other biological markers across the compounds studied; results differed by compound, dose, duration, and model.

Most purified SCBs were given to rodents by intraperitoneal injection, which limits how directly the findings apply to typical human exposure. No included study demonstrated infertility using outcomes such as mating, pregnancy, fertilization, embryo development, litter size, or live birth. Overall, this review does not establish a uniform reproductive effect across SCBs, a specific causal mechanism, greater reproductive toxicity than Δ9-tetrahydrocannabinol, or male infertility. This is an abstract-based summary; the review calls for analytically confirmed human studies and more representative exposure models.

💡 Key Findings

1
The review identifies preliminary, compound-specific reproductive toxicity signals in preclinical models, with findings varying by compound, dose, duration, and model.
High
90%
2
Reported changes involved sperm parameters, testosterone, testicular histology, and several biological markers; the abstract does not report pooled quantitative results.
High
90%
3
No included study demonstrated infertility using mating, pregnancy, fertilization, embryo, litter-size, or live-birth outcomes.
High
95%
4
Most purified compounds were administered intraperitoneally to rodents, limiting translation to typical human exposure; the evidence does not establish a uniform class effect or greater reproductive toxicity than Δ9-tetrahydrocannabinol.
High
95%

📄 Original Abstract

BACKGROUND: Synthetic cannabinoids (SCBs) are structurally and pharmacologically heterogeneous compounds. Although their acute toxicities are well described, evidence concerning male reproductive effects remains limited. This review synthesizes compound-specific preclinical findings and available human evidence, emphasizing exposure validity, study quality, and measured versus inferred mechanisms. METHODS: A narrative review was conducted using Google Scholar, PubMed/MEDLINE, Scopus, ScienceDirect, SpringerLink, Web of Science, and CrossRef. Studies evaluating male reproductive endpoints following exposure to defined SCBs or relevant street preparations were prioritized. Given the limited and heterogeneous evidence, a structured qualitative appraisal incorporating relevant SYRCLE risk-of-bias domains and exposure-model applicability was undertaken without quantitative scoring or meta-analysis. RESULTS: Reproductive evidence was identified for HU-210, JWH-018, AB-FUBINACA, CUMYL-4CN-BINACA, and the incompletely characterized street preparation Strox. Reported findings included alterations in sperm parameters, testosterone, testicular histology, redox and inflammatory biomarkers, apoptosis-associated proteins, and mitochondrial-complex protein expression. Findings varied by compound, dose, duration, and model. Most purified compounds were administered intraperitoneally to rodents, limiting translation to typical human exposure. No included study demonstrated infertility using mating, pregnancy, fertilization, embryo development, litter size, or live birth outcomes. CONCLUSION: Current evidence indicates preliminary, compound-specific signals of male reproductive toxicity in preclinical models but does not establish a uniform SCB class effect, a linear causal mechanism, greater reproductive toxicity than Δ9-tetrahydrocannabinol, or male infertility. Analytically confirmed human studies and more representative exposure models are required before clinical or regulatory fertility recommendations can be supported.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.